Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
Key facts
- Who runs it
- VA Palo Alto Health Care System
- Where
- Palo Alto, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 25 Aug 2025
- Planned end
- 1 Jan 2026
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Active Transcranial Magnetic Simulation
- Sham
- Record updated
- 13 August 2025
Who can take part
- Age
- 25 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Between age 25 and 75
- Current DSM-5 diagnosis of moderate to severe AUD (≥4 diagnostic symptoms)
- Able to attend scheduled clinic visits
- Able to read, understand and voluntarily sign Informed Consent prior to participating in any study-specific procedures or assessments
- If on a medication regimen, that regimen will be stable for the duration of the study
- Fluency in English
Who cannot take part
- Unable to safely withdraw, at least two weeks prior to treatment, from medications that increase seizure risk
- Participation in another concurrent intervention based clinical trial
- Transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI) contraindications: such as a cardiac pacemaker, cochlear implant, or an implanted device (deep brain stimulation, metal in the head, metal in the body, claustrophobia, pregnant or breastfeeding or other ferromagnetic device/objected in the head and body within 30 cm of the treatment coil
- General medical condition, disease or neurological disorder that interferes with the assessments or participation
- Have a mass lesion, cerebral infarct, or other active CNS disease, including an alcohol-related seizure or a seizure disorder. • A recent suicide attempt (defined as within the last 30 days) or presence of current suicidal plan or intent. Patients at risk for suicide will be required to establish a written safety plan involving their primary therapist before entering the study
- Taking benzodiazepine or neuroleptic medications, or any medication known to alter seizure threshold
- unstable chronic illness
- Current or lifetime history of bipolar disorder or psychosis
- Current substance abuse (except caffeine or nicotine) as determined by positive toxicology screen
- Severe impediment to vision, hearing and/or hand movement, likely to interfere with the ability to follow study protocols. • Greater than mild traumatic brain injury (defined as greater than 10 minutes loss of consciousness)
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 25 and 75 years old?
This trial is currently available in United States.
- VA Palo Alto Health Care SystemPalo Alto, United StatesContact: Luzille CowlahTaking people
About the trial
What the trial wants to find out
Alcohol Use Disorders are currently positioned as the third leading cause of preventable death in the United States, constituting a humanitarian crisis with substantial financial burden on society and medical facilities. While several pharmacological interventions exist, 60% of individuals who seek these treatments relapse to alcohol within 6 months. These high relapse rates are due in part to elevated brain response to alcohol cues in the environment. This study seeks to evaluate the efficacy of one session of functional Magnetic Resonance Imaging (fMRI) guided transcranial magnetic stimulation (TMS) as a strategy to reduce brain reactivity to alcohol cues.
The 2 groups in the trial
- Active fMRI-guided TMSTreatment being tested
Treatment: Active Transcranial Magnetic Simulation
- Sham fMRI-guided TMSSham treatment, for comparison
Treatment: Sham
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT06415721, who can take part
- Record updated
- 13 August 2025